We are live on ! Find out more
BG

Bahl & Gaynor Portfolio holdings

AUM $19.8B
1-Year Est. Return 19.53%
This Fund
S&P 500
This Quarter Est. Return
+5.56%
1 Year Est. Return
+19.53%
3 Year Est. Return
+63.97%
5 Year Est. Return
+84.2%
10 Year Est. Return
+296.44%
AUM
$14.4B
AUM Growth
+$580M
Cap. Flow
-$102M
Cap. Flow %
-0.7%
Top 10 Hldgs %
30.89%
Holding
368
New
16
Increased
155
Reduced
158
Closed
9

Top Buys

Rank Stock Value
1
ADP icon
Automatic Data Processing
ADP
+$64.6M
2
LLY icon
Eli Lilly
LLY
+$31.3M
3
MDLZ icon
Mondelez International
MDLZ
+$25.7M
4
AVGO icon
Broadcom
AVGO
+$21.7M
5
PSX icon
Phillips 66
PSX
+$11.8M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$45.1M
2
HPQ icon
HP
HPQ
+$40M
3
NEE icon
NextEra Energy
NEE
+$33M
4
PAYX icon
Paychex
PAYX
+$25.1M
5
CSCO icon
Cisco
CSCO
+$19.9M

Sector Composition

Rank Sector Weight
1 Technology 19.25%
2 Financials 16.25%
3 Healthcare 12.13%
4 Consumer Staples 10.11%
5 Industrials 9.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TPL icon
251
Texas Pacific Land
TPL
$24.5B
$1.56M 0.01%
18,000
IBM icon
252
IBM
IBM
$220B
$1.54M 0.01%
12,010
+603
+5% +$78.4K
HOMB icon
253
Home BancShares
HOMB
$6.18B
$1.53M 0.01%
+77,818
New +$1.47M
WAB icon
254
Wabtec
WAB
$49.9B
$1.51M 0.01%
19,469
-261
-1% -$19.3K
RTN
255
DELISTED
Raytheon Company
RTN
$1.51M 0.01%
6,881
-149
-2% -$31.5K
META icon
256
Meta Platforms (Facebook)
META
$1.5T
$1.49M 0.01%
7,277
+133
+2% +$25.8K
GIS icon
257
General Mills
GIS
$19.3B
$1.44M 0.01%
26,815
+2,499
+10% +$132K
XRAY icon
258
Dentsply Sirona
XRAY
$2.64B
$1.42M 0.01%
25,004
-1,334
-5% -$74.4K
QADA
259
DELISTED
QAD Inc.
QADA
$1.38M 0.01%
27,094
+96
+0.4% +$4.59K
CCMP
260
DELISTED
CMC Materials, Inc. Common Stock
CCMP
$1.37M 0.01%
9,506
-146
-2% -$20.7K
MKSI icon
261
MKS Inc
MKSI
$19.7B
$1.35M 0.01%
12,269
-1,211
-9% -$127K
WINA icon
262
Winmark
WINA
$1.27B
$1.3M 0.01%
6,577
+49
+0.8% +$8.83K
PACW
263
DELISTED
PacWest Bancorp
PACW
$1.3M 0.01%
33,963
-54,642
-62% -$2.06M
CME icon
264
CME Group
CME
$95B
$1.27M 0.01%
6,349
-1,715
-21% -$352K
CAT icon
265
Caterpillar
CAT
$394B
$1.27M 0.01%
8,610
WGO icon
266
Winnebago Industries
WGO
$885M
$1.23M 0.01%
23,205
+195
+0.8% +$9.12K
AFG icon
267
American Financial Group
AFG
$12.2B
$1.21M 0.01%
11,022
+204
+2% +$21.8K
GBCI icon
268
Glacier Bancorp
GBCI
$6.32B
$1.21M 0.01%
26,282
+10
+0% +$432
SO icon
269
Southern Company
SO
$107B
$1.21M 0.01%
18,914
-1,157
-6% -$71.7K
ALC icon
270
Alcon
ALC
$33.9B
$1.17M 0.01%
20,713
-1,260
-6% -$72.2K
CSX icon
271
CSX Corp
CSX
$93.9B
$1.17M 0.01%
48,555
+10,080
+26% +$238K
LW icon
272
Lamb Weston
LW
$7.16B
$1.16M 0.01%
13,485
-565
-4% -$45.5K
LOGM
273
DELISTED
LogMein, Inc.
LOGM
$1.1M 0.01%
12,815
-80
-0.6% -$5.94K
HI
274
DELISTED
Hillenbrand
HI
$1.09M 0.01%
32,820
RMAX icon
275
RE/MAX Holdings
RMAX
$230M
$1.04M 0.01%
27,003
+79
+0.3% +$2.84K

Similar funds

Bahl & Gaynor's Q4 2019 Portfolio in Review

As of Q4 2019, Bahl & Gaynor held 368 positions worth $14.4B, up 4.2% from $13.8B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Bahl & Gaynor's Q4 2019 filing shows 16 new, 155 increased, 158 reduced and 9 closed positions. Its largest new stake was Penske Automotive Group: 54,533 shares worth $2.74M. The largest sale was Pfizer, an estimated $45.1M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.

  • Bahl & Gaynor's largest Q4 2019 buy was Penske Automotive Group: 54,533 shares worth $2.74M.
  • Bahl & Gaynor added most to Automatic Data Processing in Q4 2019, an estimated $64.6M increase.
  • Bahl & Gaynor's biggest Q4 2019 reduction was Pfizer, cutting an estimated $45.1M.
  • Bahl & Gaynor fully exited KLA in Q4 2019, selling an estimated $3.18M.
  • Bahl & Gaynor's ten largest holdings make up 31% of its $14.4B portfolio in Q4 2019.
  • Bahl & Gaynor opened 16 new positions and closed 9 in Q4 2019.
  • Bahl & Gaynor's portfolio value rose 4.2% quarter-over-quarter to $14.4B.

Based on Bahl & Gaynor's 13F filing for Q4 2019, filed 14 Feb 2020.